For the 11 patients with HRD tumours, 2 patients had biallelic mutations (ATM and BRCA1 – both with PR), 7 patients had tumours with monoallelic HRD mutations, and 2 were unable to be determined. This evidence concerns the gene BRCA1 and neoplasm.